Validea’s guru fundamental report for ZOETIS INC (ZTS) shows that the stock rates highest using the Patient Investor model based on Warren Buffett’s strategy. ZTS is a large-cap growth stock in the Biotechnology & Drugs industry with a rating of 82%. The stock meets most of the criteria set by Warren Buffett’s strategy, making it of interest to investors looking for long-term, profitable firms with low debt and reasonable valuations. Warren Buffett is known for his successful investment strategies and modest lifestyle, despite being one of the world’s richest men. Validea offers investment research services based on the strategies of investment legends like Buffett.

Read more at Nasdaq: Warren Buffett Detailed Fundamental Analysis – ZTS